ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
Juan LiDong YangCong ZhangSisi WeiRuinian ZhaoSu-Li DaiBao-En ShanPublished in: BioMed research international (2022)
ESM1 is a hub gene in the initiation and progression of ESCA/ESCC that promotes the proliferation, migration, and invasion of esophageal cancer cells and may be a promising therapeutic target and prognostic indicator.